**Core tip:** Over 30 randomized controlled trials (RCTs) have been conducted to examine the effectiveness of exercise training on outcomes in solid organ transplant recipients. However, the synthesis of findings across studies has been limited by the lack of similar outcomes. We identified 126 unique outcomes used in RCTs of exercise training and categorized them according to the International Classification of Functioning, Disability and Health framework. Most commonly, outcomes fell into the domains of body structure and body function, whereas there were a limited number of outcomes examining activities and participation. This review highlights the need for a core set of outcomes for RCTs in exercise training for this population.

INTRODUCTION
============

As the acute morbidity and mortality associated with solid organ transplantation continues to improve, interventions that improve quality of life and long-term health outcomes are needed. Exercise training has several important health benefits for solid organ transplant (SOT) recipients, such as improving maximal aerobic capacity (VO~2~ peak), body composition and quality of life\[[@B1]\]. Exercise and physical activity also have potential effects for mitigating long-term complications post-transplant and side-effects of immunosuppressant medication such as reducing blood pressure, controlling blood glucose\[[@B2]\], managing weight gain\[[@B3]\], improving muscle\[[@B4]\] and bone strength\[[@B5]\], and reducing fatigue\[[@B6]-[@B8]\]. A limitation of the current literature on exercise for SOT is the inability to combine outcomes from studies due to the wide range of reported outcomes. In a systematic review of exercise training in SOT recipients conducted in 2012 by Didsbury et al\[[@B1]\], the authors included 15 randomized controlled trials (RCTs) with 28 unique outcomes. The majority of outcomes were related to cardiovascular parameters (VO~2~ peak, blood pressure, cholesterol), with fewer studies examining body composition, frailty indicators or quality of life. The authors were therefore hampered in their ability to conduct meta-analyses, which limited the conclusions of their comprehensive review.

The inability to synthesize data from studies in the field of SOT is of particular concern, as this is a small population and studies on exercise training are often conducted at single transplant centres with relatively small sample sizes. In order to gain greater statistical power to draw conclusions, studies need to be combined using knowledge synthesis approaches, which require common outcomes. Inconsistencies in the reporting of outcomes can affect the conclusions of systematic reviews and may contribute to reporting bias\[[@B9]\]. Therefore, in order to facilitate standard reporting of key outcomes across studies, the development of core outcomes sets for clinical trials is gaining more attention\[[@B10],[@B11]\].

The International Classification of Functioning, Disability and Health (ICF) is an established framework developed by the World Health Organization and is commonly used in rehabilitation. The ICF is designed to describe health and health-related status from biological, personal and societal perspectives\[[@B12]\]. The framework classifies human function into four domains: Body functions; body structures; activities and participation; and environmental factors\[[@B12]\]. These domains match well with the goals of exercise training and physical rehabilitation programs; specifically to identify, measure and treat physical impairments (body function and structure); to reverse or normalize activity limitations; and to enhance participation in all settings\[[@B13]\]. Using the ICF to map the outcomes of the current literature on exercise training in SOT recipients will assist in classifying the breadth of outcomes that have been used in the studies to date and also in identifying any domains that are understudied in this population. This information can provide a starting point for developing a core set of standard outcomes\[[@B10]\] for clinical trials of exercise and physical rehabilitation in SOT recipients.

The objectives of this systematic review were to identify the outcome measures that have been used in RCTs of exercise training in SOT recipients and to link these outcomes to the ICF framework.

MATERIALS AND METHODS
=====================

Data sources and search strategy
--------------------------------

This systematic review is in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement\[[@B14]\]. A librarian designed and performed electronic literature searches of Medline from inception until May 2016. The search was then adapted for EMBASE, CINAHL, Cochrane, Scopus, and Web of Science and run on these databases. Search terms included organ transplantation, transplant recipients, graft recipient, heart, lung, kidney, pancreas, liver, exercise, exercise therapy, rehab, rehabilitation, resistance training, physical education, training, physical activity, and physical exertion (Table [1](#T1){ref-type="table"}). The searches were limited to RCTs, published in English, and in humans. One investigator (Stacey Konidis) also conducted hand searches of the reference lists of all the studies that met the inclusion criteria to identify additional relevant articles.

###### 

Electronic search strategy used in MEDLINE

  ------------- -------------------------------------------------------------------------------
  Search \#     Keywords and number of records identified
  Search \#1    Organ transplantation (110179)
  Search \#2    Transplantation conditioning (7738)
  Search \#3    Transplant recipients (195)
  Search \#4    "Transplant recipient\$" (27594)
  Search \#5    1 or 2 or 3 or 4 (122169)
  Search \#6    Exercise/or Exercise Therapy/or exercise\$ (192344)
  Search \#7    Rehab\$/or rehabilitation (151761)
  Search \#8    Resistance training/or "physical education and training"/or training (181282)
  Search \#9    "Physical activity" (47446)
  Search \#10   Physical exertion (11451)
  Search \#11   6 or 7 or 8 or 9 or 10 (474657)
  Search \#12   5 and 11 (2399)
  Search \#13   Heart or lung or kidney or pancreas or liver (1433618)
  Search \#14   12 and 13 (2200)
  Search \#15   Limit 14 to humans (2156)
  Search \#16   Limit 14 to animals (76)
  Search \#17   15 not 16 (2121)
  Search \#18   Limit 17 to randomized controlled trial (60)
  ------------- -------------------------------------------------------------------------------

Criteria for including studies in the review
--------------------------------------------

We selected all RCTs that investigated the effect of exercise training in SOT recipients. We included trials that compared the effects of exercise training programs to standard care as well as trials that compared two or more different exercise training programs in SOT recipients. In the case of multiple publications of the same study, we considered all of them if the outcomes measures were different. We excluded studies that did not have an isolated exercise intervention group (*i.e*., those that examined the effect of a drug combined with exercise). We also excluded non-English articles and conference abstracts. One investigator (Stacey Konidis) reviewed the study titles and abstracts to determine potential study eligibility. When this investigator was uncertain, a second reviewer (Tania Janaudis-Ferreira) was consulted. Two investigators independently reviewed the full texts of the articles to determine eligibility (Stacey Konidis and Tania Janaudis-Ferreira).

Data extraction and synthesis
-----------------------------

Two reviewers (Stacey Konidis and Cecile Beaurepaire) performed the data extraction and tabulation. A third reviewer (Tania Janaudis-Ferreira) double-checked the extracted data. Outcome measures were abstracted using a standard form and imported into a spreadsheet, sorted into primary and secondary outcomes and classified according to four domains of the ICF (body functions, body structures, activities and participation, and environmental factors). Information about the exercise interventions and patient populations were also retrieved. Considering the purpose of this review, study quality or risk of bias assessments of the included studies were not deemed to be necessary.

RESULTS
=======

Literature search
-----------------

The electronic and hand searches led to the identification of 522 articles. After excluding 109 duplicates, there were 413 articles left for title and abstract screening. Following the study title and abstract screening, 366 were considered to be unrelated to the objectives of the review. Of the 47 articles that remained for full-text analysis, 12 were excluded. This left a total of 35\[[@B2]-[@B5],[@B15]-[@B45]\] articles for inclusion in this review. The study flow and reasons for exclusion are shown in Figure [1](#F1){ref-type="fig"}.

![PRISMA 2009 flow diagram. From: Moher et al\[[@B14]\]. For more information, visit [www.prisma-statement.org](www.prisma-statement.org).](WJT-6-774-g001){#F1}

Review of studies and outcome domains assessed
----------------------------------------------

The studies included were designed to compare the effects of exercise training programs to usual care or to another exercise training program and reported on transplantation of heart (*n* = 21), kidney (*n* = 9), lung (*n* = 3), and liver (*n* = 2). A total of 1313 patients were randomized in the 35 studies. Description of the exercise programs and other details about the studies is presented in Table [2](#T2){ref-type="table"}.

###### 

Description of studies

  **Ref**.                      **Country**     **Year**   **Organ**   **Time-post transplant (wk)**   **Treatment duration (wk)**   **Randomized patients[1](#T2FN1){ref-type="table-fn"}**   **Exercise intervention**                                                                                         **Comparison**
  ----------------------------- --------------- ---------- ----------- ------------------------------- ----------------------------- --------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------
  Braith et al\[[@B5]\]         United States   1996       Heart       \> 8                            24                            16                                                        Lumbar extension 1 d/wk; variable resistance exercises 2 d/wk                                                     Usual care
  Braith et al\[[@B4]\]         United States   1998       Heart       \> 8                            24                            16[2](#T2FN2){ref-type="table-fn"}                        Lumbar extension 1 d/wk; variable resistance exercises 2 d/wk                                                     Usual care
  Kobashigawa et al\[[@B15]\]   United States   1999       Heart       \> 2                            26                            27                                                        Individualized cardiac rehabilitation (strengthening, flexibility, and moderate aerobic exercises) 1-3 d/wk       Usual care (unstructured therapy at home)
  Painter et al\[[@B16]\]       United States   2002       Kidney      4-8                             48                            167                                                       Independent home-based exercise 4 d/wk                                                                            Usual care
  Mitchell et al\[[@B17]\]      United States   2003       Lung        \> 8                            26                            16                                                        Lumbar extension resistance exercise 1 d/wk and walking program                                                   Usual care (walking program)
  Painter et al\[[@B18]\]       United States   2003       Kidney      \> 4                            48                            96                                                        Independent home-based exercise 4 d/wk                                                                            Usual care
  Braith et al\[[@B19]\]        United States   2005       Heart       \> 8                            24                            15                                                        Variable resistance exercises 2 d/wk                                                                              Usual care
  Juskowa et al\[[@B20]\]       Poland          2006       Kidney      \> 0.5                          4-5                           69                                                        Strength exercise training 7 d/wk                                                                                 Usual care
  Krasnoff et al\[[@B3]\]       United States   2006       Liver       \> 8                            40                            151                                                       Cardiovascular exercise training 3 d/wk                                                                           Usual care
  Bernardi et al\[[@B21]\]      Italy           2007       Heart       \> 24                           24                            26                                                        Stationary bicycle; 30 min/5 d per week                                                                           Usual care
  Karapolat et al\[[@B22]\]     Turkey          2007       Heart       Mean 14-17                      8                             38                                                        Hospital-based exercise program (flexibility, stretching, aerobic, strengthening, breathing, relaxation) 3 d/wk   Home-based exercise program (flexibility, stretching, aerobic, strengthening, breathing, relaxation) 3 d/wk
  Braith et al\[[@B23]\]        United States   2008       Heart       \> 8                            12                            20                                                        Aerobic treadmill exercise                                                                                        Usual care
  Karopola et al\[[@B24]\]      Turkey          2008       Heart       Mean 14-17                      8                             38[3](#T2FN3){ref-type="table-fn"}                        Hospital-based exercise program (flexibility, stretching, aerobic, strengthening, breathing, relaxation) 3 d/wk   Home-based exercise program (flexibility, stretching, aerobic, strengthening, breathing, relaxation) 3 d/wk
  Pierce et al\[[@B25]\]        United States   2008       Heart       \> 8                            12                            20                                                        Aerobic exercise training                                                                                         Usual care
  Wu et al\[[@B26]\]            Taiwan          2008       Heart       \> 52                           8                             37                                                        Resistance and aerobic training 3 d/wk                                                                            Usual care
  Haykowsky et al\[[@B27]\]     Canada          2009       Heart       \> 26                           12                            23                                                        Aerobic 5 d/wk and strength training 2 d/wk                                                                       Usual care
  Mandel et al\[[@B28]\]        United States   2009       Liver       6-12                            12                            50                                                        Targeted lower body resistance strengthening exercise 3-4 d/wk                                                    Usual care (walking program)
  Hermann et al\[[@B29]\]       Denmark         2011       Heart       \> 52                           8                             27                                                        Aerobic interval training program 3 d/wk                                                                          Usual care
  Ihle et al\[[@B30]\]          Germany         2011       Lung        \> 52                           4                             60                                                        Inpatient rehabilitation (exercise training 4 d/wk and aerobic session 5 d/wk)                                    Outpatient physiotherapy
  Christensen et al\[[@B31]\]   Denmark         2012       Heart       Mean 84                         8                             [4](#T2FN4){ref-type="table-fn"}                          High-intensity aerobic interval training 3 d/wk                                                                   Usual care
  Langer et al\[[@B2]\]         Belgium         2012       Lung        1-6                             12                            40                                                        Aerobic and resistance training 3 d/wk                                                                            Usual care
  Nytrøen et al\[[@B32]\]       Norway          2012       Heart       52-416                          52                            52                                                        High-intensity aerobic interval training 3 d/wk                                                                   Usual care
  Rustad et al\[[@B33]\]        Norway          2012       Heart       52-416                          12                            52                                                        High-intensity aerobic interval training 3 d/wk                                                                   Usual care
  Kawauchi et al\[[@B34]\]      Brazil          2013       Heart       \< 1                            to hospital discharge         22                                                        10-phase incremental exercise program (breathing, active resistance exercises, aerobic exercises, stretching)     Institution exercise routine (breathing, stretching walking) 5 d/wk
  Kouidi et al\[[@B35]\]        Greece          2013       Kidney      \> 52                           26                            24                                                        Aerobic exercise and strength training 4 d/wk                                                                     Usual care
  Nytrøen et al\[[@B36]\]       Norway          2013       Heart       52-416                          52                            52[5](#T2FN5){ref-type="table-fn"}                        High-intensity aerobic interval training 3 d/wk                                                                   Usual care
  Dall et al\[[@B37]\]          Denmark         2014       Heart       \> 52                           12 (5 mo washout)             17                                                        High-intensity aerobic interval training 3 d/wk                                                                   Moderate biking exercise 3 d/wk
  Monk-Hansen et al\[[@B38]\]   Denmark         2014       Heart       \> 52                           8                             30                                                        High intensity training 3 d/wk                                                                                    Usual care
  Pascoalino et al\[[@B39]\]    Brazil          2015       Heart       \> 52                           12                            42                                                        Endurance exercise training 3 d/wk                                                                                Usual care
  Pooranfar et al\[[@B40]\]     Iran            2013       Kidney      104-156                         10                            44                                                        Aerobic and resistance training 3 d/wk                                                                            Usual care
  Riess et al\[[@B41]\]         Canada          2013       Kidney      \> 26                           12                            31                                                        Endurance and strength training 2 d/wk                                                                            Usual care
  Tzvetanov et al\[[@B42]\]     United States   2014       Kidney      \> 4                            52                            17                                                        Resistance exercise training 2 d/wk (as well as behaviour and nutrition)                                          Usual care
  Dall et al\[[@B43]\]          Denmark         2015       Heart       \> 52                           12 (5 mo washout)             17[6](#T2FN6){ref-type="table-fn"}                        High-intensity aerobic interval training 3 d/wk                                                                   Moderate biking exercise 3 d/wk
  Greenwood et al\[[@B44]\]     England         2015       Kidney      \< 52                           12                            60                                                        Home-based aerobic training and resistance training 3 d/wk                                                        Usual care
  Karelis et al\[[@B45]\]       Canada          2015       Kidney      6-8                             16                            24                                                        Resistance training 3 d/wk (once a week in hospital and 2 × /week at home)                                        Usual care (no exercise)

Does not add to 1313 since some patients included in more than one study;

Same patients as Braith 1996;

Same patients as Karolopat 2007;

Same patients as Hermann 2011;

Same patients as Nytrøen 2012;

Same patients as Dall 2014. BMD: Bone mineral density; HR: Heart rate; BP: Blood pressure; HRQOL: Health-related quality-of-life; CVD: Cardiovascular disease; BMI: Body mass index; METs: Metabolic unit of task; HRRe: Heart rate reserve; HRR1: Heart rate recovery; CRI: Chronotropic response index; CRP: C-reactive protein; IL-6: Interleukin-6; TNF-a: Tumor necrosis factor-alpha; sICAM-1: Intercellular adhesion molecule-1; 6MWD: 6 minute walk distance; FVC: Forced vital capacity; HRV: Heart rate variability; BRS: Baroreflex sensitivity.

Table [3](#T3){ref-type="table"} outlines the outcome measures that were used in each study. In total, there were 126 outcome measures. Of the 126 outcome measures, 62 were used as primary outcome measures in at least one study. The most commonly occurring primary outcomes were peak VO~2~ (*n* = 13), SF-36 (*n* = 8), and muscle strength (*n* = 7).

###### 

List of outcome measures by study

  **Ref**.                      **Year**   **Organ group**   **Primary outcome measures**                                                                                                                                                                                                                                                           **Secondary outcome measures**
  ----------------------------- ---------- ----------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Braith et al\[[@B5]\]         1996       Heart             Bone mineral density (body and regional: Femur neck, lumbar vertebra)                                                                                                                                                                                                                  Bone mineral content Total bone calcium Acute rejection episodes
  Braith et al\[[@B4]\]         1998       Heart             Body mass Fat-free mass Fat mass Muscle strength (upper and lower body)                                                                                                                                                                                                                Percent body fat Acute rejection episodes
  Kobashigawa et al\[[@B15]\]   1999       Heart             Blood pressure (peak and resting) Heart rate (peak and resting) Anaerobic threshold Exercise duration (to exhaustion) Peak ventilation Peak VO~2~ Peak workload Ventilatory equivalent for carbon dioxide and oxygen                                                                   Muscle strength (lower limb)
  Painter et al\[[@B16]\]       2002       Kidney            Body mass index Body weight Fat mass/body fat Lean tissue mass Percent body fat Blood pressure (peak) Muscle strength (quadriceps) Peak ventilation Peak VO~2~ SF-36                                                                                                                   Self-reported activity level (frequency, type, length, and intensity of exercise) Blood creatinine Blood urea nitrogen levels Hematocrit Hemoglobin Bone mineral density Peak workload Rating of perceived exertion (Borg) Peak respiratory exchange ratio Immunosuppression use (type, dose)
  Mitchell et al\[[@B17]\]      2003       Lung              Bone mineral density (lumbar spine)                                                                                                                                                                                                                                                    Acute rejection episodes Muscle strength (lumbar extensor)
  Painter et al\[[@B18]\]       2003       Kidney            Cholesterol (TC, HDL) Body mass index Total CVD risk (Framingham) Blood pressure Peak workload (METs)                                                                                                                                                                                  Blood lipids Incidence of diabetes Smoking status
  Braith et al\[[@B19]\]        2005       Heart             Muscle composition (fiber types) Muscle metabolic enzyme activity                                                                                                                                                                                                                      Muscle strength (upper and lower body)
  Juskowa et al\[[@B20]\]       2006       Kidney            Blood lipids Cholesterol (TC, HDL, LDL) Body mass index                                                                                                                                                                                                                                Blood calcium level Blood creatinine Blood electrolytes Blood glucose Blood phosphorus Blood protein levels (albumin, fibrinogen, total protein level) Enzyme levels (alanine transferase, alkaline phosphatase, aspartate aminotransferase) Folate concentrations Hemoglobin Interleukin-18 Total-homocysteine Vitamin B12 Blood pressure Muscle strength (upper limbs) Peak expiratory flow
  Krasnoff et al\[[@B3]\]       2006       Liver             Body mass index Body weight Bone mineral content Bone mineral density Fat mass/body fat Lean tissue mass Percent body fat Muscle strength (quadriceps) Peak VO~2~ SF-36 Peak respiratory exchange ratio Nutritional intake (Block-95 - calories/day; protein, carb and fat calories)   Rating of perceived exertion (Borg)
  Bernardi et al\[[@B21]\]      2007       Heart             Baroceptor control of blood pressure Baroceptor control of heart rate                                                                                                                                                                                                                  Blood pressure; Heart rate Neck pressure RR interval Anaerobic threshold CO~2~ production Exercise duration (to exhaustion) Peak ventilation Peak VO~2~; Peak workload Ventilatory equivalent for CO~2~ and oxygen
  Karapolat et al\[[@B22]\]     2007       Heart             Peak VO~2~ Beck depression inventory SF-36 State-trait anxiety inventory                                                                                                                                                                                                               
  Braith et al\[[@B23]\]        2008       Heart             Endothelial function (flow-mediated dilation)                                                                                                                                                                                                                                          Blood glucose Blood lipids Cholesterol (TC, HDL, LDL) Oxidative stress-induced lipid peroxidation Plasma norepinephrine Serum metabolic and hematologic indicators Body mass Acute rejection episodes Blood pressure (resting and peak) Brachial artery diameter Exercise duration (to exhaustion) Peak VO~2~
  Karapolat et al\[[@B24]\]     2008       Heart             Chronotropic response index Heart rate recovery Heart rate reserve Peak VO~2~                                                                                                                                                                                                          Duke Treadmill Score
  Pierce et al\[[@B25]\]        2008       Heart             C-reactive protein Interleukin-6 Serum metabolic profile Soluble cell adhesion molecules (sICAM-1) Tumour necrosis factor-alpha Muscle vasodilation (forearm and calf)                                                                                                                 Blood glucose Cholesterol (TC, HDL, LDL) Cytomegalovirus IgG status White blood cell levels Acute rejection episodes Blood pressure (resting) Heart rate (peak and resting) Exercise duration (to exhaustion) Rating of perceived exertion (Borg) Peak respiratory exchange ratio
  Wu et al\[[@B26]\]            2008       Heart             Muscle endurance (quadriceps) Muscle strength (quadriceps) Peak VO~2~ World Health Organization Questionnaire on Quality of Life - BREF                                                                                                                                                Daily physical activity Blood pressure Heart rate (resting and peak) Nutritional intake (caloric intake questionnaire) Peak ventilation Peak workload Rating of perceived exertion (Borg)
  Haykowsky et al\[[@B27]\]     2009       Heart             Peak VO~2~                                                                                                                                                                                                                                                                             Lean tissue mass (total and leg) Blood pressure (peak) Endothelial function (endothelial-dependent vasodilation, endothelial-independent vasodilation, reactive hyperemia index) Heart rate (peak) Left ventricular systolic function Muscle strength (upper and lower body) Peak power output Peak respiratory exchange ratio
  Mandel et al\[[@B28]\]        2009       Liver             6MWD Muscle strength (lower body) Chronic liver disease questionnaire (CLDQ) SF-36 (physical function/limitations)                                                                                                                                                                     
  Hermann et al\[[@B29]\]       2011       Heart             Peak VO~2~                                                                                                                                                                                                                                                                             Blood creatinine Blood glucose; Blood lipids Blood protein levels (adiponectin, MR-proANP, NT-proBNP, provasopressin/copeptin) Cholesterol Hemoglobin High sensitive C-reactive protein Interleukin-6 Serum insulin Tumour necrosis factor-alpha Body mass index; Body weight Hip-waist ratio Blood pressure (resting) Brachial artery diameter Endothelial function (flow-mediated vasodilation, nitroglycerin-induced vasodilation) Heart rate (resting) Peak power output
  Ihle et al\[[@B30]\]          2011       Lung              6MWD Peak VO~2~ SF-36 St. George's Respiratory Questionnaire                                                                                                                                                                                                                           Heart rate (peak and resting) Anaerobic threshold Oxygen uptake at anaerobic threshold Peak workload Peak respiratory exchange ratio Ventilatory reserve and capacity
  Christensen et al\[[@B31]\]   2012       Heart             Hospital Anxiety and Depression Scale                                                                                                                                                                                                                                                  Peak VO~2~
  Langer et al\[[@B2]\]         2012       Lung              SF-36 Daily walking time (time spend in different postures: sedentary, standing, walking)                                                                                                                                                                                              Daily steps Movement intensity Time spent in moderate intense activities Blood lipids Body weight Bone mineral density Blood pressure 6MWD Muscle strength (quadriceps and handgrip) Peak workload Mood status SF-36 Forced expiratory volume Respiratory muscle force Incidence of morbidity (diabetes, hyperlipidemia, hypertension, osteoporosis)
  Nytrøen et al\[[@B32]\]       2012       Heart             Peak VO~2~                                                                                                                                                                                                                                                                             Blood lipids Blood protein levels (NT-proBNP) C-reactive protein Interleukin-6, 8 and 10 levels Body mass index; Body weight; % body fat Chronotropic response index Glycemic control parameters Blood pressure (peak and resting) Heart rate (peak and resting) Heart rate recovery and reserve Stroke volume (O~2~ pulse; resting and peak) Anaerobic threshold Exercise duration (to exhaustion) Muscle strength (quadriceps and hamstrings) Peak ventilation Rating of perceived exertion (Borg) SF-36 Visual Analog Scale (subjective difference in HRQoL) Peak respiratory exchange ratio
  Rustad et al\[[@B33]\]        2012       Heart             Echocardiographic parameters (rest and during exercise; systolic and diastolic parameters) Peak VO~2~                                                                                                                                                                                  Biochemical parameters Blood pressure Cardiac allograft vasculopathy (coronary angiography) Cardiac output Heart rate (resting and peak) Stroke volume Peak workload Peak respiratory exchange ratio
  Kawauchi et al\[[@B34]\]      2013       Heart             6MWD Forced vital capacity Respiratory muscle force/strength                                                                                                                                                                                                                           Muscle strength (upper and lower limbs) Maximum expiratory/inspiratory pressure
  Kouidi et al\[[@B35]\]        2013       Kidney            Baroreflex sensitivity Heart rate variability parameters (SDNN, rMSSD, pNN50, LF, HF, LF/HF)                                                                                                                                                                                           Baroreflex effectiveness index Blood pressure (peak and resting) Heart rate (peak and resting) Exercise duration (to exhaustion) Peak ventilation Peak VO~2~
  Nytrøen et al\[[@B36]\]       2013       Heart             Cardiac allograft vasculopathy (intravascular ultrasound and virtual histology)                                                                                                                                                                                                        Blood creatinine Blood glucose Blood lipids C-reactive protein Cholesterol (TC, HDL, LDL) Hemoglobin Interleukin-6, 8 and 10 levels Body mass index Body water (total) Body weight Bone mass Lean tissue mass Percent body fat Visceral fat scale Basal metabolic rate Glycemic control parameters Metabolic age Muscle strength (quadriceps and hamstrings) Peak VO~2~
  Dall et al\[[@B37]\]          2014       Heart             Peak VO~2~                                                                                                                                                                                                                                                                             Body weight Blood pressure Heart rate (peak and resting) Heart rate recovery Heart rate reserve CO~2~ production Peak ventilation Peak workload Peak respiratory exchange ratio
  Monk-Hansen et al\[[@B38]\]   2014       Heart             Echocardiography parameters (systolic and diastolic function)                                                                                                                                                                                                                          Body mass index Blood pressure Heart rate (peak and resting) Peak VO~2~ Peak workload
  Pascoalino et al\[[@B39]\]    2015       Heart             Arterial stiffness (carotid-femoral pulse wave velocity) Blood pressure (ambulatory; peak and resting)                                                                                                                                                                                 Plasma norepinephrine Heart rate (peak and resting) Anaerobic threshold CO~2~ production Exercise duration (to exhaustion) Peak VO~2~ Peak respiratory exchange ratio Respiratory compensation point
  Pooranfar et al\[[@B40]\]     2013       Kidney            Blood lipids Cholesterol (TC, HDL, LDL) Sleep quality and quantity questionnaire (self-report; Pittsburgh Sleep Quality Index)                                                                                                                                                         
  Riess et al\[[@B41]\]         2013       Kidney            Peak VO~2~                                                                                                                                                                                                                                                                             Cholesterol (TC, HDL) Lean tissue mass Total CVD risk (Framingham) Arterial pressure (mean) Arterial stiffness (pulse wave velocity) Arteriovenous oxygen difference (a-vO~2~) Blood pressure (ambulatory; peak and resting) Cardiac output Heart rate (peak); Stroke volume Systemic vascular endurance Muscle strength (lower body) Peak workload SF-36 Peak respiratory exchange ratio
  Tzvetanov et al\[[@B42]\]     2014       Kidney            Glomerular filtration rate SF-36 Adherence to training and follow-up Employment status                                                                                                                                                                                                 Blood creatinine; Blood glucose; Blood lipids Cholesterol (TC, HDL, LDL) Hemoglobin Body mass index Body weight Bone mineral content Lean tissue mass Percent body fat Arterial stiffness (carotid-femoral pulse wave velocity Blood pressure Carotid intima-media thickness Muscle strength
  Dall et al\[[@B43]\]          2015       Heart             Blood glucose Blood protein levels (adiponectin, orosomucoid, YLK 40) Interleukin-6 Serum insulin Tumour necrosis factor-alpha Arterial stiffness (augmentation index) Endothelial function (reactive hyperemia index) Hospital Anxiety and Depression Scale SF-36                     Body weight Homeostasis model assessment Heart rate (peak) Peak VO~2~ Peak respiratory exchange ratio
  Greenwood et al\[[@B44]\]     2015       Kidney            Muscle strength (quadriceps)                                                                                                                                                                                                                                                           Arterial stiffness (pulse wave velocity) Blood pressure (peak and resting) Heart rate (peak and resting) STS-60 Peak VO~2~ Body mass index; Body weight Waist girth Glomerular filtration rate high-sensitivity C-reactive protein interleukin-6 Fetuin A Tumor necrosis factor-alpha tumor necrosis factor receptors 1 and 2 SF-36 Duke Activity Status Index
  Karelis et al\[[@B45]\]       2015       Kidney            World Health Organization-5 Well-Being Index Muscle strength index Adherence to training and follow-up (feasibility)                                                                                                                                                                   Body weight Body height Body mass index Waist girth Hip girth Fat mass/body fat Lean tissue mass Cholesterol (TC, HDL, LDL) Blood glucose Blood pressure Peak VO~2~

SF-36: Short-form 36; TC: Total cholesterol; HDL: High-density lipoprotein fraction of cholesterol; LDL: Low-density lipoprotein fraction of cholesterol; RR-interval: Inter-beat interval (heart rate); BREF: A shorter version of the original; rMSSD: Root-mean-square of successive NN interval differences; pNN50: Percentage value of NN50 count; LF: Low-frequency components; HF: High-frequency components; CVD: Cardio-vascular disease; STS-60: Sit-to-stand 60.

Each outcome measure was linked to an ICF domain and the list is shown in Table [4](#T4){ref-type="table"}. The majority of outcomes fell into the body function domain (*n* = 93). Fourteen outcome measures were linked to the activities and participation, 5 to body structures, 2 to environmental factors and 2 described outcomes were unclassified in the ICF. Frailty indicators such as grip strength (*n* = 1), fatigue (*n* = 0) or gait speed (6-minute-walk) (*n* = 3) were rarely used. Ten multi-dimensional questionnaires were used in the studies reviewed.

###### 

International Classification of Functioning, Disability and Health outcome classifications

  **ICF component**              **Domain**                                                                                           **Category**                         **Outcome measures**                                         **Count primary[1](#T4FN1){ref-type="table-fn"}**   **Organ group**
  ------------------------------ ---------------------------------------------------------------------------------------------------- ------------------------------------ ------------------------------------------------------------ --------------------------------------------------- ----------------------------
  Body Function                  Global mental functions                                                                              b134                                 Sleep quality and quantity                                   1                                                   Kidney
                                                                                                                                      b152                                 Mood status                                                  0                                                   Lung
                                 Functions of the cardiovascular system (heart functions)                                             b410                                 Cardiac output                                               0                                                   Heart, kidney
                                 b410                                                                                                 Carotid intima-media thickness       0                                                            Kidney                                              
                                 b410                                                                                                 Echocardiographic parameters         2                                                            Heart                                               
                                 b410                                                                                                 Endothelial function                 2                                                            Heart                                               
                                 b410                                                                                                 Left ventricular systolic function   0                                                            Heart                                               
                                 b410                                                                                                 RR interval                          0                                                            Heart                                               
                                 b410                                                                                                 Stroke volume                        0                                                            Heart, kidney                                       
                                 b410                                                                                                 Systemic vascular endurance          0                                                            Kidney                                              
                                 Functions of the cardiovascular system (heart rate)                                                  b4100                                Heart rate                                                   1                                                   Heart, kidney, lung
                                                                                                                                      b4100                                Heart rate recovery                                          1                                                   Heart
                                                                                                                                      b4100                                Heart rate reserve                                           1                                                   Heart
                                                                                                                                      b4100                                Heart rate variability                                       1                                                   Kidney
                                 Functions of the cardiovascular system                                                               b410-429                             Baroceptor control of blood pressure                         1                                                   Heart
                                                                                                                                      b410-429                             Baroceptor control of heart rate                             1                                                   Heart
                                                                                                                                      b410-429                             Baroflex effectiveness index                                 0                                                   Kidney
                                                                                                                                      b410-429                             Baroflex sensitivity                                         1                                                   Kidney
                                                                                                                                      b410-429                             Chronotropic response index                                  1                                                   Heart
                                                                                                                                      b410-429                             Total CVD risk                                               1                                                   Kidney
                                                                                                                                      b410-429                             Cardiac allograft vasculopathy                               1                                                   Heart
                                 Functions of the cardiovascular system (blood vessel                                                 b415                                 Arterial stiffness                                           3                                                   Heart, kidney
                                 functions)                                                                                           b415                                 Brachial artery diameter                                     0                                                   Heart
                                 Functions of the cardiovascular system (blood                                                        b420                                 Arterial pressure                                            0                                                   Kidney
                                 pressure functions)                                                                                  b420                                 Blood pressure                                               4                                                   Heart, kidney, lung
                                                                                                                                      b420                                 Neck pressure                                                0                                                   Heart
                                 Functions of the cardiovascular system (oxygen-carrying functions of the blood)                      b4301                                Arteriovenous oxygen difference                              0                                                   Kidney
                                 Functions of the hematological and immunological                                                     b430-439                             Biochemical parameters                                       0                                                   Heart
                                 systems                                                                                              b430-439                             Blood calcium level                                          0                                                   Kidney
                                                                                                                                      b430-439                             Blood creatinine                                             0                                                   Heart, kidney
                                                                                                                                      b430-439                             Blood electrolytes                                           0                                                   Kidney
                                                                                                                                      b430-439                             Blood glucose                                                1                                                   Heart, kidney
                                                                                                                                      b430-439                             Blood lipids                                                 2                                                   Heart, kidney, lung
                                                                                                                                      b430-439                             Blood phosphorus                                             0                                                   Kidney
                                                                                                                                      b430-439                             Blood protein levels                                         1                                                   Heart, kidney
                                                                                                                                      b430-439                             Blood urea nitrogen levels                                   0                                                   Kidney
                                                                                                                                      b430-439                             C-reactive protein                                           1                                                   Heart
                                                                                                                                      b430-439                             Cholesterol                                                  3                                                   Heart, kidney
                                                                                                                                      b430-439                             Folate concentrations                                        0                                                   Kidney
                                                                                                                                      b430-439                             Hematocrit                                                   0                                                   Kidney
                                                                                                                                      b430-439                             Hemoglobin                                                   0                                                   Heart, kidney
                                                                                                                                      b430-439                             High sensitive C-reactive protein                            0                                                   Heart
                                                                                                                                      b430-439                             Interleukin levels                                           2                                                   Heart, kidney
                                                                                                                                      b430-439                             Plasma norepinephrine                                        0                                                   Heart
                                                                                                                                      b430-439                             Soluble cell adhesion molecules                              1                                                   Heart
                                                                                                                                      b430-439                             Total-homocysteine                                           0                                                   Kidney
                                                                                                                                      b430-439                             Tumour necrosis factor-alpha                                 2                                                   Heart
                                                                                                                                      B430-439                             Tumor necrosis factor receptor                               0                                                   Kidney
                                                                                                                                      b435                                 Cytomegalovirus IgG status                                   0                                                   Heart
                                                                                                                                      b435                                 White blood cell levels                                      0                                                   Heart
                                                                                                                                      b435                                 Acute rejection episodes                                     0                                                   Heart, lung
                                 Functions of the respiratory system (respiration functions)                                          b440                                 Forced expiratory volume                                     0                                                   Lung
                                 functions)                                                                                           b440                                 Forced vital capacity                                        1                                                   Heart
                                                                                                                                      b440                                 Maximum expiratory/inspiratory pressure                      0                                                   Heart
                                                                                                                                      b440                                 Peak expiratory flow                                         0                                                   Kidney
                                                                                                                                      b440                                 Peak respiratory exchange ratio                              1                                                   Heart, kidney, liver, lung
                                                                                                                                      b440                                 Respiratory compensation point                               0                                                   Heart
                                                                                                                                      b440                                 Ventilatory reserve and capacity                             0                                                   Lung
                                 Functions of the respiratory system (respiration rate)                                               b4400                                CO~2~ production                                             0                                                   Heart
                                                                                                                                      b4400                                Oxygen uptake at anaerobic threshold                         0                                                   Lung
                                                                                                                                      b4400                                Peak ventilation                                             2                                                   Heart, kidney
                                                                                                                                      b4400                                Peak VO~2~                                                   13                                                  Heart, kidney, liver, lung
                                                                                                                                      b4400                                Ventilatory equivalent for carbon dioxide and oxygen         1                                                   Heart
                                 Functions of the respiratory system (respiratory muscle functions)                                   b445                                 Respiratory muscle force/strength                            1                                                   Heart, lung
                                 Functions of the cardiovascular system (general physical endurance)                                  b4550                                Rating of perceived exertion                                 0                                                   Heart, kidney, liver
                                 Functions related to the digestive, metabolism and the endocrine system                              b530                                 Body mass index                                              4                                                   Heart, kidney, liver
                                 endocrine system                                                                                     b530                                 Body weight/mass                                             3                                                   Heart, kidney, liver, lung
                                                                                                                                      b530                                 Fat mass/body fat                                            3                                                   Heart, kidney, liver
                                                                                                                                      b530                                 Fat-free mass                                                1                                                   Heart
                                                                                                                                      b530                                 Hip girth                                                    0                                                   Kidney
                                                                                                                                      b530                                 Hip-waist ratio                                              0                                                   Heart
                                                                                                                                      b530                                 Lean tissue mass                                             2                                                   Heart, kidney, liver
                                                                                                                                      b530                                 Percent body fat                                             2                                                   Heart, kidney, liver
                                                                                                                                      b530                                 Visceral fat scale                                           0                                                   Heart
                                                                                                                                      b530                                 Waist girth                                                  0                                                   Kidney
                                 General metabolic functions, unspecified                                                             b5400                                Basal metabolic rate                                         0                                                   Heart
                                                                                                                                      b5400                                Metabolic age                                                0                                                   Heart
                                 General metabolic functions, other, specified                                                        B5408                                Maximal metabolic units                                      1                                                   Kidney
                                 Functions related to metabolism and the endocrine system                                             b540-559                             Enzyme levels                                                0                                                   Kidney
                                 system                                                                                               b540-559                             Fetuin A                                                     0                                                   Kidney
                                                                                                                                      b540-559                             Oxidative stress-induced lipid peroxidation                  0                                                   Heart
                                                                                                                                      b540-559                             Serum insulin                                                1                                                   Heart
                                                                                                                                      b540-559                             Serum metabolic and/or hematologic profile                   1                                                   Heart
                                                                                                                                      b540-559                             Vitamin B~12~                                                0                                                   Kidney
                                                                                                                                      b540-559                             Glycemic control parameters                                  0                                                   Heart, kidney
                                                                                                                                      b540-559                             Muscle metabolic enzyme activity                             1                                                   Heart
                                                                                                                                      b545                                 Body water                                                   0                                                   Heart
                                                                                                                                      b545                                 Homeostasis model assessment                                 0                                                   Heart
                                 Functions of the genitourinary and reproductive functions (urinary functions)                        b610-639                             Glomerular filtration rate                                   1                                                   Kidney
                                 Neuromusculoskeletal and movement-related functions (muscle power functions)                         b730                                 Peak workload/power output                                   1                                                   Heart, kidney, lung
                                                                                                                                      b730                                 Muscle strength                                              7                                                   Heart, kidney, liver, lung
                                                                                                                                      b730-b749                            Muscle vasodilation                                          1                                                   Heart
                                                                                                                                      b740                                 Muscle endurance                                             1                                                   Heart
  Body structure                 Structures related to movement - additional musculoskeletal structures related to movement (bones)   s7700                                Bone mass                                                    0                                                   Heart
                                                                                                                                      s7700                                Bone mineral content                                         1                                                   Heart, kidney, liver
                                                                                                                                      s7700                                Bone mineral density                                         3                                                   Heart, kidney, liver, lung
                                                                                                                                      s7700                                Total bone calcium                                           0                                                   Heart
                                                                                                                                      s7702                                Muscle composition (fibre types)                             1                                                   Heart
  Activities and participation   Mobility - walking and moving                                                                        d410                                 STS-60                                                       0                                                   Kidney
  participation                  Mobility - walking and moving (walking)                                                              d450                                 Daily steps                                                  0                                                   Lung
                                                                                                                                      d450                                 Daily walking time                                           1                                                   Lung
                                                                                                                                      d450                                 6 Minute Walk Distance                                       3                                                   Heart, liver, lung
                                                                                                                                      d450                                 Anaerobic threshold                                          1                                                   Heart, lung
                                 Mobility - walking and moving                                                                        d450-469                             Daily physical activity                                      0                                                   Heart
                                                                                                                                      d450-469                             Movement intensity                                           0                                                   Lung
                                                                                                                                      d450-469                             Self-reported activity level                                 0                                                   Kidney
                                                                                                                                      d450-469                             Time spent in moderate intense activities                    0                                                   Lung
                                                                                                                                      d450-469                             Duke Treadmill Score                                         0                                                   Heart
                                                                                                                                      d450-469                             Exercise duration                                            1                                                   Heart, kidney
                                 Managing diet and fitness                                                                            d5701                                Caloric intake                                               0                                                   Heart
                                                                                                                                      d5701                                Nutritional intake                                           1                                                   Liver
                                 Major life areas (work and employment)                                                               d840-859                             Employment status                                            1                                                   Kidney
  Environmental factors          Products or substances for personal consumption, other specified                                     e1108                                Smoking status                                               0                                                   Kidney
                                 Drugs                                                                                                e1101                                Immunosuppression use                                        0                                                   Kidney
  Questionnaires                                                                                                                                                           DASI                                                         0                                                   Kidney
                                                                                                                                                                           Quality of Life Profile for Chronic Diseases Questionnaire   1                                                   Lung
                                                                                                                                                                           SF-36                                                        8                                                   Heart, kidney, liver, lung
                                                                                                                                                                           St. George's Respiratory Questionnaire                       1                                                   Lung
                                                                                                                                                                           State-Trait Anxiety Inventory                                1                                                   Heart
                                                                                                                                                                           Beck Depression Inventory                                    1                                                   Heart
                                                                                                                                                                           Hospital Anxiety and Depression Scale                        2                                                   Heart
                                                                                                                                                                           Visual Analog Scale (change in HRQoL)                        0                                                   Heart
                                                                                                                                                                           WHOQOL-BREF                                                  2                                                   Heart, kidney
  Not covered by ICF                                                                                                                                                       Chronic Liver Disease Questionnaire                          1                                                   Liver
                                                                                                                                                                           Incidence of morbidity                                       0                                                   Kidney, lung
                                                                                                                                                                           Adherence to training and follow-up                          2                                                   Kidney

Count Primary: Count of studies that used this measure as a primary measure. RR-interval: Inter-beat interval (heart rate); CVD: Cardio-vascular disease; STS-60: Sit-to-stand 60; SF-36: Short-form 36; HRQoL: Health-related quality of life; WHOQOL-BREF: A shorter version of the original World Health Organization Quality of Life Questionnaire; DASI: Duke Activity Status Index.

DISCUSSION
==========

Physical rehabilitation in SOT patients strives to minimize the impairments associated with prolonged chronic illness, allowing individuals to improve their ability to carry out daily tasks and activities and to participate in life roles. When selecting outcome measures to use in clinical trials of SOT recipients, it is important to capture changes across all domains that are relevant to the primary goals of the physical rehabilitation intervention. We have used the ICF categories to classify the outcome measures used in RCTs of exercise interventions after SOT. From this systematic review, we have learned that the outcome measures used in these RCTs vary widely. This finding is in line with the results of similar systematic reviews conducted in other populations (*e.g*., individuals with critical illness, post-surgery and stroke)\[[@B11]\] Some of the studies focused on multiple primary outcomes and others used just two or three. In total, 62 different primary outcomes were used with the most common being peak VO~2~ (*n* = 13) and the SF-36 (*n* = 8). Most of the outcomes used fell into the body functions domain (*n* = 93) with very few in the activities and participation domain (*n* = 14). Few studies included outcomes that are also considered frailty indicators. These are important outcomes as frailty is present in many SOT recipients and can have a negative impact on transplant outcomes\[[@B6]-[@B8]\].

As we did, Disdbury et al\[[@B1]\] found that the most commonly used outcome measure was VO~2~ peak. However, this is an expensive test that requires complex equipment as well as expertise from a professional to interpret the results. Functional exercise capacity tests that are more relevant to patients' activities and participation in daily life and less costly to administer should be considered.

Disdbury et al\[[@B1]\] were unable to merge data on health-related quality-of-life (HRQoL) measures since so many different questionnaires were used. We found that 11 of the RCTs analyzed used multi-dimensional questionnaires as an outcome measure with several using more than one. These questionnaires each cover many different ICF categories. For instance, Cieza and Stucki\[[@B46]\] have linked individual questions from the short-form-36 (SF-36) questionnaire to ICF domains and found that this questionnaire incorporates at least 21 ICF codes. Linking individual items on HRQoL questionnaires could help researchers select a questionnaire that covers many ICF codes and that would be most suited to be part of the core set of outcome measures recommended, thus making it possible to meaningfully merge data from multiple studies.

A core set of outcome measures to be used in all of these populations would be helpful to minimize and standardize the number of outcomes used in this patient group. While it is important to conduct a comprehensive assessment, the use of a large number of outcome measures can be burdensome for both patients and evaluators. Ideally, the core set of variables should cover all four domains of the ICF, *i.e*., they need to cover all aspects of the health condition. Furthermore, the core set of variables needs to include outcomes that are common to all organ groups. Many of the issues that affect physical function and exercise capacity are common across the transplant types despite each SOT having its own unique characteristics and challenges\[[@B47]\]. Some of the pre-transplant issues that limit physical function are specific to the failing organ, but the physiological changes associated with severe chronic disease, deconditioning and nutritional depletion are common to all groups\[[@B48]\]. Post-transplant issues that limit physical function vary depending on the phase of recovery, but include things such as extended hospital and intensive care stay, prolonged sedentary time, immunosuppressant medications and episodes of organ rejection\[[@B48]\]. Outcome measures that relating to these commonalities and to increasing physical function would be suitable for inclusion in the core set of variables. However, there are some organ specific issues that may be important to address differently among the groups (*e.g*., the effects of exercise in the denervation of the heart after transplant or the effects of exercise on early onset of diabetes after kidney transplant) and researchers should be encouraged to include secondary outcomes to address them.

The selection of outcome measures should reflect the length of time since the transplant and whether the course of recovery has been complicated. For example, the main goal of physical rehabilitation for acute phase post-transplant is usually to improve basic mobility and activities of daily living while rehabilitation for long-term recipients is generally focused on improving their exercise capacity and levels of physical activity to prevent cardiovascular complications. When considering appropriate outcomes, is also important to take into account their psychometric properties\[[@B49]\]. Knowing the validity of the outcomes in the transplant population can help researchers with sample size calculations for interventional studies and justify the use of the selected primary outcomes.

None of the studies reviewed included an economic evaluation of the exercise programs and the potential cost savings if SOT recipients experience less long-term cardiovascular disease and fewer hospital readmission related to frailty and physical disability. Although robust economic studies can be challenging, they may be important to convince healthcare funders that exercise programs can be cost-effective and have a positive impact on transplant outcomes and survival. Exercise programs also need to be more readily available for transplant recipients as lack of availability of post-transplant exercise programs has been identified for example in Canada\[[@B50]\].

Limitations
-----------

A limitation of this systematic review is the inclusion of only RCTs. There are other studies on exercise training in SOT recipients that use different research designs, especially observational studies using pre-post designs that were not included. We chose this strategy because RCTs are of the highest quality of study design. We assumed that investigators conducting RCTs have chosen their outcomes carefully and that this group of studies is representative of all rehabilitation trials in transplant recipients. We have also limited our search to studies published in English, which may have reduced our sample size.

There is little standardization in outcome measures used in RCTs of exercise interventions in SOT recipients. Outcome measures for clinical trials should also be selected based on their psychometric properties, stage post transplantation and severity of impairments of the patient population. Further research is needed to develop consensus on a standardized core set of outcomes to measure the effectiveness of such interventions. The ICF framework can be used to select appropriate outcomes that cross all domains and that would be appropriate to all SOT recipients.

COMMENTS
========

Background
----------

Over 30 randomized controlled trials (RCTs) have been conducted to examine the effectiveness of exercise training on outcomes in solid organ transplant (SOT) recipients. However, the synthesis of findings across studies has been limited by the lack of similar outcomes across studies. The objectives of this systematic review were to identify the outcome measures that have been used in RCTs of exercise training in SOT recipients and to link these outcomes to the International Classification of Functioning, Disability and Health (ICF) framework.

Research frontiers
------------------

Between 1996 and 2015 more than 30 RCTs were published on the effects of exercise training in SOT recipients. Taken together, the results of these RCTs show that exercise training improves maximal aerobic capacity, muscle strength, body composition, cardiopulmonary variables and quality of life. There is little evidence for the effect of exercise in physical activity and participation in SOT recipients. In a systematic review of exercise training in SOT recipients conducted in 2012 by Didsbury et al, the authors included 15 RCTs with 28 unique outcomes. The majority of outcomes were related to cardiovascular parameters (VO~2~ peak, blood pressure, cholesterol), with fewer studies examining body composition, frailty indicators or quality of life. The authors were therefore hampered in their ability to conduct meta-analyses, which limited the conclusions of their comprehensive review.

Innovations and breakthroughs
-----------------------------

There are numerous studies examining the role of exercise training to improve outcomes following SOT. Exercise training has several important health benefits for SOT recipients, such as improving maximal aerobic capacity (VO~2~ peak), body composition and quality of life. A limitation of the current literature on exercise for SOT is the inability to combine outcomes from studies due to the wide range of reported outcomes.

Applications
------------

This systematic review suggests that there is a need to develop consensus on a standardized core set of outcomes to measure the effectiveness of exercise interventions in SOT. A standardized core set of outcomes would facilitate standard reporting of key outcomes across studies.

Terminology
-----------

The ICF is an established framework developed by the World Health Organization and is commonly used in rehabilitation. The ICF is designed to describe health and health-related status from biological, personal and societal perspectives. The framework classifies human function into four domains: body functions; body structures; activities and participation; and environmental factors. These domains match well with the goals of exercise training and physical rehabilitation programs; specifically to identify, measure and treat physical impairments (body function and structure); to reverse or normalize activity limitations; and to enhance participation in all settings.

Peer-review
-----------

It is a well written review concerning several domains to assess the function outcome of patients with organ transplants subjected to exercise training. It is very helpful for the readers.

Conflict-of-interest statement: All the authors declare that they have no competing interests.

Data sharing statement: The original tables are available from the corresponding author at tania.janaudis-ferreira\@mcgill.ca.

Manuscript source: Invited manuscript

Specialty type: Transplantation

Country of origin: Canada

Peer-review report classification

Grade A (Excellent): A

Grade B (Very good): B

Grade C (Good): C

Grade D (Fair): D

Grade E (Poor): 0

Peer-review started: July 1, 2016

First decision: September 5, 2016

Article in press: October 24, 2016

P- Reviewer: Kelesidis T, Kin T, Pan SC, Shi YJ S- Editor: Ji FF L- Editor: A E- Editor: Lu YJ

[^1]: Author contributions: Janaudis-Ferreira T designed the research question and protocol, screened titles and abstracts and drafted the manuscript; Mathur S assisted with the interpretation of the findings and provided critical feedback on the manuscript; Konidis S screened titles, abstracts and full-texts, assisted with extracting the data and drafting the manuscript; Tansey CM assisted with data extraction and tabulation and manuscript writing; Beaurepaire C assisted with data extraction and tabulation; all authors read and approved the final manuscript.

    Correspondence to: Tania Janaudis-Ferreira, PhD, School of Physical and Occupational Therapy, McGill University, 3630 Promenade Sir-William-Osler, Montreal, QC H3G1Y5, Canada. <tania.janaudis-ferreira@mcgill.ca>

    Telephone: +1-514-3985326 Fax: +1-514-3988193
